VYNE Therapeutics Inc. Common Stock (VYNE)

Typically moves ±95.52% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-08-14 APPROXIMATE
search

Since Aug 12, 2021, VYNE Therapeutics Inc. Common Stock (VYNE) has reported earnings 18 times. On average the shares move ±95.52% post-earnings, with a positive reaction 61.1% of the time. Its largest post-earnings gain was +1606.67% (Mar 09, 2023) and its largest decline was -31.38% (Aug 12, 2021). The next earnings report is predicted for 2026-08-14 (approximate).

Earnings reactions

How VYNE moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

18

Avg Abs. Movement

±95.52%

Positive %

61.1%

Negative %

38.9%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Nov 06, 2025 ☀ PRE +5.36% open_in_new
Aug 14, 2025 ☀ PRE -1.27% open_in_new
May 08, 2025 ☀ PRE -3.36% open_in_new
Mar 06, 2025 ☀ PRE +0% open_in_new
event

Earnings Count

18

Total earnings in dataset

trending_up

Avg Abs. Movement

±95.52%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 6 →
6
Funds holding
$49825
Total value held
Buying
1 added · 0 reduced

Frequently asked about VYNE earnings

When does VYNE Therapeutics Inc. Common Stock report earnings next? expand_more

VYNE Therapeutics Inc. Common Stock (VYNE)'s next earnings date is approximate for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does VYNE stock move after earnings? expand_more

Over 18 reports, VYNE has moved an average of ±95.52% the session after earnings, closing higher 61.1% of the time.

What was VYNE's biggest post-earnings move? expand_more

VYNE's largest post-earnings gain on record was +1606.67% on Mar 09, 2023, and its largest decline was -31.38% on Aug 12, 2021.

Where can I find VYNE Therapeutics Inc. Common Stock's SEC filings? expand_more

All of VYNE Therapeutics Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.